Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

2

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

2 companies

Hypera

Market Cap: R$15.3b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$22.01

7D

5.9%

1Y

-8.1%

Ouro Fino Saúde Animal Participações

Market Cap: R$1.3b

Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.

OFSA3

R$24.54

7D

-0.8%

1Y

12.6%